Contact

All Stories

  1. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery

    Article • The Journal of Heart and Lung Transplantation, September 2022, Elsevier

    Dr. Erika Berman Rosenzweig

  2. Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension

    Article • Annals of the American Thoracic Society, June 2022, American Thoracic Society

    Dr. Erika Berman Rosenzweig

  3. The Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Pulmonary Hypertension Patients

    Article • December 2021, Research Square

    Dr. Erika Berman Rosenzweig

  4. Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation

    Article • The Journal of Heart and Lung Transplantation, December 2021, Elsevier

    Dr. Erika Berman Rosenzweig

  5. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry

    Article • European Respiratory Journal, June 2021, European Respiratory Society (ERS)

    Steven Abman, Dr. Erika Berman Rosenzweig

  6. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

    Article • Pulmonary Circulation, March 2021, Wiley

    Dr. Erika Berman Rosenzweig

  7. Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID‐19?’”

    Article • Pulmonary Circulation, July 2020, Wiley

    Dr. Erika Berman Rosenzweig

  8. A rare childhood case of Behcet's disease and chronic thromboembolic pulmonary hypertension

    Article • Journal of Cardiac Surgery, May 2020, Wiley

    Dr. Erika Berman Rosenzweig

  9. Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic

    Article • Pulmonary Circulation, April 2020, Wiley

    Dr. Erika Berman Rosenzweig

  10. Could pulmonary arterial hypertension patients be at a lower risk from severe COVID‐19?

    Article • Pulmonary Circulation, April 2020, Wiley

    Dr. Erika Berman Rosenzweig

  11. Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    Dr. Erika Berman Rosenzweig

  12. Sildenafil Use in Children with Pulmonary Hypertension

    Article • The Journal of Pediatrics, February 2019, Elsevier

    Dr. Erika Berman Rosenzweig

  13. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management

    Article • European Respiratory Journal, January 2019, European Respiratory Society (ERS)

    Dr. Erika Berman Rosenzweig, Rolf Berger

  14. Increasing Opportunity for Lung Transplant in Interstitial Lung Disease With Pulmonary Hypertension

    Article • The Annals of Thoracic Surgery, December 2018, Elsevier

    Dr. Erika Berman Rosenzweig

  15. Eisenmenger Syndrome in Pregnancy

    Article • A&A Practice, November 2018, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  16. Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension

    Article • Circulation Genomic and Precision Medicine, October 2018, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig, Professor Allan Lawrie

  17. Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease

    Article • Genome Medicine, July 2018, Springer Science + Business Media

    Dunbar Ivy, Dr. Erika Berman Rosenzweig

  18. Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report

    Article • American Review of Respiratory Disease, July 2018, American Thoracic Society

    Dr. Erika Berman Rosenzweig

  19. The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension

    Article • The Journal of Pediatrics, June 2018, Elsevier

    Dr. Erika Berman Rosenzweig

  20. Position paper for the organization of ECMO programs for cardiac failure in adults

    Article • Intensive Care Medicine, February 2018, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  21. Eisenmenger Syndrome and Pregnancy

    Article • ASAIO Journal, January 2018, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  22. Update on pulmonary arterial hypertension research: proceedings from a meeting of experts

    Article • Current Medical Research and Opinion, December 2017, Taylor & Francis

    Dr. Erika Berman Rosenzweig

  23. Mutations in BMPR2 are not present in patients with pulmonary hypertension associated with congenital diaphragmatic hernia

    Article • Journal of Pediatric Surgery, November 2017, Elsevier

    Dr. Erika Berman Rosenzweig

  24. PVDOMICS

    Article • Circulation Research, October 2017, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  25. A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry

    Article • The Journal of Pediatrics, September 2017, Elsevier

    Dr. Erika Berman Rosenzweig

  26. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia

    Article • The Journal of Pediatrics, September 2017, Elsevier

    Dr. Erika Berman Rosenzweig

  27. Portopulmonary hypertension in children: a rare but potentially lethal and under-recognized disease

    Article • Pulmonary Circulation, July 2017, SAGE Publications

    Dr. Erika Berman Rosenzweig

  28. Novel Modified Potts shunt design for Pulmonary Hypertension

    Article • Annals of the American Thoracic Society, April 2017, American Thoracic Society

    Dr. Erika Berman Rosenzweig

  29. The “Central Sport Model”

    Article • ASAIO Journal, January 2017, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  30. Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy

    Article • Traffic, November 2016, Wiley

    Dr. Erika Berman Rosenzweig

  31. Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

    Article • International Journal of Cardiology, November 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  32. Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: Lessons learned

    Article • The Journal of Heart and Lung Transplantation, October 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  33. Chronic Thromboembolic Pulmonary Hypertension, Pregnancy, and a Pulmonary Endarterectomy: A Rare Challenge

    Article • Pulmonary Circulation, September 2016, SAGE Publications

    Dr. Erika Berman Rosenzweig

  34. Clinical Classification in Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

    Article • Pulmonary Circulation, September 2016, SAGE Publications

    Dr. Erika Berman Rosenzweig

  35. An Observational Study of Inhaled-Treprostinil Respiratory-Related Safety in Patients with Pulmonary Arterial Hypertension

    Article • Pulmonary Circulation, September 2016, SAGE Publications

    Dr. Erika Berman Rosenzweig

  36. Extracorporeal Membrane Oxygenation for Cardiopulmonary Failure During Pregnancy and Postpartum

    Article • The Annals of Thoracic Surgery, September 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  37. Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study

    Article • The Lancet Respiratory Medicine, April 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  38. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension

    Article • The Journal of Pediatrics, March 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  39. Using Registries to Understand Clinical Practice

    Article • Journal of the American College of Cardiology, March 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  40. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    Article • The Lancet Respiratory Medicine, February 2016, Elsevier

    Professor Olivier SITBON, Dr. Erika Berman Rosenzweig, Professor Zhi-Cheng JING

  41. Therapeutic Options for Childhood Pulmonary Hypertension

    Article • Advances in Pulmonary Hypertension, January 2016, Pulmonary Hypertension Association

    Dr. Erika Berman Rosenzweig

  42. PH Roundtable: Pediatric Pulmonary Hypertension Guidelines Highlights and Challenges

    Article • Advances in Pulmonary Hypertension, January 2016, Pulmonary Hypertension Association

    Dr. Erika Berman Rosenzweig

  43. FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

    Article • International Journal of Cardiology, January 2016, Elsevier

    Dr. Erika Berman Rosenzweig

  44. Predicting Peak Oxygen Uptake From the 6-Minute Walk Test in Patients With Pulmonary Hypertension

    Article • Journal of Cardiopulmonary Rehabilitation and Prevention, January 2016, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  45. Pediatric Pulmonary Hypertension

    Article • Circulation, November 2015, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  46. Pulmonary hypertension in chronic lung disease of infancy

    Article • Current Opinion in Pediatrics, April 2015, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  47. Balloon atrial septostomy in pulmonary arterial hypertension: Effect on survival and associated outcomes

    Article • The Journal of Heart and Lung Transplantation, March 2015, Elsevier

    Dr. Erika Berman Rosenzweig

  48. Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

    Article • Biomarker Insights, January 2015, SAGE Publications

    Dr. Erika Berman Rosenzweig

  49. Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

    Article • CHEST Journal, August 2014, Elsevier

    Dr. Erika Berman Rosenzweig

  50. Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom

    Article • PLoS ONE, July 2014, PLOS

    Dr. Erika Berman Rosenzweig, Dr Seyed Mehdi Nouraie

  51. Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy

    Article • PEDIATRICS, June 2014, American Academy of Pediatrics (AAP)

    Dr. Erika Berman Rosenzweig

  52. Survival Differences in Pediatric Pulmonary Arterial Hypertension

    Article • Journal of the American College of Cardiology, May 2014, Elsevier

    Dr. Erika Berman Rosenzweig

  53. An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease

    Article • American Journal of Respiratory and Critical Care Medicine, March 2014, American Thoracic Society

    Dr. Erika Berman Rosenzweig

  54. Effects of Dose and Age on Adverse Events Associated with Tadalafil in the Treatment of Pulmonary Arterial Hypertension

    Article • Pulmonary Circulation, March 2014, SAGE Publications

    Dr. Erika Berman Rosenzweig

  55. EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis

    Article • CHEST Journal, February 2014, Elsevier

    Dr. Erika Berman Rosenzweig

  56. Extracorporeal Membrane Oxygenation With Subclavian Artery Cannulation in Awake Patients With Pulmonary Hypertension

    Article • ASAIO Journal, January 2014, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  57. Extracorporeal Membrane Oxygenation as a Novel Bridging Strategy for Acute Right Heart Failure in Group 1 Pulmonary Arterial Hypertension

    Article • ASAIO Journal, January 2014, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  58. Four- and Seven-Year Outcomes of Patients With Congenital Heart Disease–Associated Pulmonary Arterial Hypertension (from the REVEAL Registry)

    Article • The American Journal of Cardiology, January 2014, Elsevier

    Dr. Erika Berman Rosenzweig

  59. Pediatric Pulmonary Hypertension

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Professor Damien Bonnet, Dr. Erika Berman Rosenzweig

  60. Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

    Article • Clinics in Chest Medicine, December 2013, Elsevier

    Dr. Erika Berman Rosenzweig

  61. Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension

    Article • Pulmonary Circulation, December 2013, SAGE Publications

    Dr. Erika Berman Rosenzweig

  62. A Novel Channelopathy in Pulmonary Arterial Hypertension

    Article • New England Journal of Medicine, July 2013, New England Journal of Medicine (NEJM/MMS)

    Dr. Erika Berman Rosenzweig

  63. Outcomes of Congenital Diaphragmatic Hernia in the Modern Era of Management

    Article • The Journal of Pediatrics, July 2013, Elsevier

    Dr. Erika Berman Rosenzweig

  64. Upper-Body Extracorporeal Membrane Oxygenation as a Strategy in Decompensated Pulmonary Arterial Hypertension

    Article • Pulmonary Circulation, April 2013, SAGE Publications

    Dr. Erika Berman Rosenzweig

  65. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

    Article • Nature Genetics, March 2013, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  66. Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension

    Article • American Journal of Respiratory and Critical Care Medicine, March 2013, American Thoracic Society

    Dr. Erika Berman Rosenzweig

  67. Genetic determinants of haemolysis in sickle cell anaemia

    Article • British Journal of Haematology, February 2013, Wiley

    Dr. Erika Berman Rosenzweig, Dr Seyed Mehdi Nouraie

  68. Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

    Article • Cardiovascular Therapeutics, January 2013, Wiley

    Dr. Erika Berman Rosenzweig

  69. Clinical Trials in Neonates and Children: Report of the Pulmonary Hypertension Academic Research Consortium Pediatric Advisory Committee

    Article • Pulmonary Circulation, January 2013, SAGE Publications

    Dr. Erika Berman Rosenzweig

  70. Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  71. Updating Clinical Endpoint Definitions

    Article • Pulmonary Circulation, January 2013, SAGE Publications

    Dr. Erika Berman Rosenzweig

  72. Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children

    Article • The American Journal of Cardiology, December 2012, Elsevier

    Dr. Erika Berman Rosenzweig

  73. Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension

    Article • The American Journal of Cardiology, November 2012, Elsevier

    Dr. Erika Berman Rosenzweig

  74. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe

    Article • Haematologica, September 2012, Ferrata Storti Foundation (Haematologica)

    Dr. Erika Berman Rosenzweig, Dr Seyed Mehdi Nouraie

  75. Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery

    Article • Progress in Cardiovascular Diseases, September 2012, Elsevier

    Dr. Erika Berman Rosenzweig

  76. Successful Treatment of Severe Mechanical Mitral Valve Thrombosis With Tissue Plasminogen Activator in a 7-Month-Old Infant

    Article • Pediatric Cardiology, August 2012, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  77. Pediatric Pulmonary Arterial Hypertension and Hyperthyroidism: A Potentially Fatal Combination

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2012, Endocrine Society

    Dr. Erika Berman Rosenzweig

  78. Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension

    Article • Circulation Cardiovascular Genetics, June 2012, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  79. Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension

    Article • Pediatric Pulmonology, April 2012, Wiley

    Dr. Erika Berman Rosenzweig

  80. Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United Kingdom

    Article • Circulation, September 2011, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig, Dr Seyed Mehdi Nouraie

  81. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

    Article • Blood, July 2011, American Society of Hematology

    Dr. Erika Berman Rosenzweig

  82. Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT

    Article • Circulation, May 2011, Wolters Kluwer Health

    David Lederer, Dr. Erika Berman Rosenzweig

  83. Ambrisentan for Pulmonary Arterial Hypertension Due to Congenital Heart Disease

    Article • The American Journal of Cardiology, May 2011, Elsevier

    Dr. Erika Berman Rosenzweig

  84. Pulmonary hypertension in children with sickle cell disease

    Article • Expert Review of Respiratory Medicine, April 2011, Taylor & Francis

    Dr. Erika Berman Rosenzweig

  85. Common Atrium and Pulmonary Vascular Disease

    Article • Pediatric Cardiology, February 2011, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  86. Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease

    Article • JIMD Reports, January 2011, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  87. Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings

    Article • The American Journal of Cardiology, November 2010, Elsevier

    Dr. Erika Berman Rosenzweig

  88. Effectiveness of Transition from Intravenous Epoprostenol to Oral/Inhaled Targeted Pulmonary Arterial Hypertension Therapy in Pediatric Idiopathic and Familial Pulmonary Arterial Hypertension

    Article • The American Journal of Cardiology, May 2010, Elsevier

    Dr. Erika Berman Rosenzweig

  89. Tadalafil for the treatment of pulmonary arterial hypertension

    Article • Expert Opinion on Pharmacotherapy, December 2009, Informa Healthcare

    Dr. Erika Berman Rosenzweig

  90. Non-congenital heart disease associated pediatric pulmonary arterial hypertension

    Article • Progress in Pediatric Cardiology, December 2009, Elsevier

    Dr. Erika Berman Rosenzweig

  91. Pulmonary arterial hypertension in children: Diagnostic work-up and challenges

    Article • Progress in Pediatric Cardiology, December 2009, Elsevier

    Dr. Erika Berman Rosenzweig

  92. Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years

    Article • British Journal of Haematology, August 2009, Wiley

    Dr. Erika Berman Rosenzweig

  93. Polymorphism in the Angiotensin II Type 1 Receptor (AGTR1) is Associated With Age at Diagnosis in Pulmonary Arterial Hypertension

    Article • The Journal of Heart and Lung Transplantation, April 2009, Elsevier

    Dr. Erika Berman Rosenzweig

  94. Determinants of Right Ventricular Ejection Fraction in Pulmonary Arterial Hypertension

    Article • CHEST Journal, March 2009, Elsevier

    Dr. Erika Berman Rosenzweig

  95. Pulmonary arterial hypertension in children: A Medical Update

    Article • The Indian Journal of Pediatrics, January 2009, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  96. Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial Hypertension

    Article • The Journal of Heart and Lung Transplantation, June 2008, Elsevier

    Dr. Erika Berman Rosenzweig

  97. Pulmonary arterial hypertension in children: a medical update

    Article • Current Opinion in Pediatrics, June 2008, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  98. Plasma serotonin levels are normal in pulmonary arterial hypertension

    Article • Pulmonary Pharmacology & Therapeutics, February 2008, Elsevier

    David Lederer, Dr. Erika Berman Rosenzweig

  99. Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA(Leu) gene (m.3243A>G)

    Article • Journal of Inherited Metabolic Disease, January 2008, Wiley

    Dr. Erika Berman Rosenzweig

  100. The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertension

    Article • Cardiology in the Young, October 2007, Cambridge University Press

    Dr. Erika Berman Rosenzweig

  101. Platelet-Derived Growth Factor Is Increased in Pulmonary Capillary Hemangiomatosis

    Article • CHEST Journal, March 2007, Elsevier

    Dr. Erika Berman Rosenzweig

  102. Emerging treatments for pulmonary arterial hypertension

    Article • Expert Opinion on Emerging Drugs, October 2006, Informa Healthcare

    Dr. Erika Berman Rosenzweig

  103. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension

    Article • Pulmonary Pharmacology & Therapeutics, October 2006, Elsevier

    David Lederer, Dr. Erika Berman Rosenzweig

  104. Reply

    Article • Journal of the American College of Cardiology, May 2006, Elsevier

    Dr. Erika Berman Rosenzweig

  105. Pulmonary Arterial Hypertension

    Article • Treatments in Respiratory Medicine, January 2006, Springer Science + Business Media

    Dr. Erika Berman Rosenzweig

  106. A SECONDARY CARE PERSPECTIVE ON THE STEPPING-DOWN OF INHALED CORTICOSTEROID THERAPY IN PATIENTS WITH STABLE ASTHMA

    Article • CHEST Journal, October 2005, Elsevier

    Dr. Erika Berman Rosenzweig

  107. von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension

    Article • CHEST Journal, October 2005, Elsevier

    Dr. Erika Berman Rosenzweig

  108. Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension

    Article • Journal of the American College of Cardiology, August 2005, Elsevier

    Dr. Erika Berman Rosenzweig

  109. Idiopathic pulmonary arterial hypertension in children

    Article • Current Opinion in Pediatrics, June 2005, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  110. New predictors of outcome in idiopathic pulmonary arterial hypertension

    Article • The American Journal of Cardiology, January 2005, Elsevier

    Dr. Erika Berman Rosenzweig

  111. Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension

    Article • Circulation, August 2004, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  112. Identical Twins With Primary Pulmonary Hypertension

    Article • CHEST Journal, March 2004, Elsevier

    Dr. Erika Berman Rosenzweig

  113. Pulmonary arterial hypertension in children

    Article • Pediatric Pulmonology, January 2004, Wiley

    Dr. Erika Berman Rosenzweig

  114. Pulmonary hypertension in Jarcho-Levin syndrome

    Article • American Journal of Medical Genetics, January 2002, Wiley

    Dr. Erika Berman Rosenzweig

  115. Eisenmenger syndrome in ventricular septal defect patients

    Article • Progress in Pediatric Cardiology, December 2001, Elsevier

    Dr. Erika Berman Rosenzweig

  116. Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension

    Article • Expert Opinion on Investigational Drugs, May 2001, Informa Healthcare

    Dr. Erika Berman Rosenzweig

  117. Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects

    Article • Circulation, April 1999, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig

  118. Late Left Ventricular Function After Surgery for Children With Chronic Symptomatic Mitral Regurgitation

    Article • Circulation, December 1997, Wolters Kluwer Health

    Dr. Erika Berman Rosenzweig